Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern

Full text
Author(s):
Dellavance, Alessandra [1] ; Gallindo, Cristiane ; Soares, Mariana Guanaes [1] ; da Silva, Neusa Pereira [1] ; Mortara, Renato Arruda [2] ; Coelho Andrade, Luis Eduardo [1]
Total Authors: 6
Affiliation:
[1] Univ Fed Sao Paulo, Div Rheumatol, BR-04023062 Sao Paulo - Brazil
[2] Univ Fed Sao Paulo, Microbiol Immunol & Parasitol Div, BR-04023062 Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: RHEUMATOLOGY; v. 48, n. 6, p. 632-637, JUN 2009.
Web of Science Citations: 17
Abstract

Objectives. To report on a novel IIF pattern specifically associated with antibodies to DNA topo I. Methods. A novel compound IF pattern, designated Scl-70 pattern, was characterized in routine ANA-HEp-2 IIF screening. Within the last 3 years, all serum samples presenting the Scl-70 pattern at the ANA-HEp2 IIF screening were tested for anti-topo I reactivity. Conversely, 16 serum samples with known anti-topo I reactivity and affinity-purified anti-topo I antibody preparations were tested for the Scl-70 pattern. Results. The Scl-70 pattern comprised the staining of five cellular regions: nucleus, nucleolus and cytoplasm in interphase cells; nucleolar organizing region (NOR) and chromosomes in mitotic cells. All 81 serum samples selected as Scl-70 pattern reacted with topo I. All 16 anti-topo I samples and antibody preparations reproduced the Scl-70 pattern. This compound IF pattern was consistently observed in different commercial HEp-2 cell slides and in home-made slides with HEp-2 cells and human fibroblasts fixed with alternative protocols. Double IIF experiments demonstrated the co-localization of topo I and human upstream binding factor at the NOR. Conclusions. The Scl-70 pattern belongs to the group of compound IF patterns that hold strong association with the respective autoantibody specificities, such as that observed with centromere protein F (CENP-F) and nuclear mitotic apparatus-1 (NuMA-1) protein. The identification of the Scl-70 pattern at routine ANA-HEp-2 IIF screening may lead to implementation of specific tests for the identification of anti-topo I antibodies. In addition, the Scl-70 pattern outlines cellular domains other than those previously reported for topo I, which is of interest for further understanding the roles of this enzyme in cell biology. (AU)